Easton Capital Investment Group
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2016 · 12012 · 12 dated
BiotechSan Francisco, US
Philip Fung(Executive Officer, Director)
BoardRoberto Sanabria(Director)in
Co-investorsExpaKaiser Permanente VenturesLionBirdNew Leaf Venture PartnersSands Capital Ventures
BiotechMalvern, US
Mark Lupher(Executive Officer)Dominick C. Colangelo(Executive Officer, Director)
BoardJames W. Broderick, M.D.(Director)Geert-Jan Mulder(Director)inJohn Friedman(Director)inHarold R. Werner(Director)
Co-investorsEaston CapitalSofinnova VenturesForbion
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Fund performance · per public LP disclosures
as of Mar 2024| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Easton Hunt New York, LPLPs: Empire State Development – New York Ventures | 2003 | — | — | 0.35x | 0.15x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).